(Q35134608)

6 August 2017

1 reference

title

Breast cancer and post-menopausal hormone therapy (English)

1 reference

6 August 2017

Kenemans P

1

1 reference

6 August 2017

Bosman A

series ordinal

2

1 reference

6 August 2017

language of work or name

1 reference

1 March 2003

1 reference

Best Practice and Research: Clinical Endocrinology and Metabolism

6 August 2017

published in

1 reference

6 August 2017

volume

17

1 reference

6 August 2017

issue

1

1 reference

6 August 2017

page(s)

123-137

1 reference

Hormone replacement therapy and breast cancer

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900084-2

7 January 2021

Hormone replacement therapy and breast cancer morbidity, mortality and recurrence

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900084-2

7 January 2021

Hormone-replacement therapy and breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900084-2

7 January 2021

Recent trends in breast cancer incidence and mortality

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900084-2

7 January 2021

Epidemiology of breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900084-2

7 January 2021

Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900084-2

7 January 2021

Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900084-2

7 January 2021

Hormone replacement and the menopause: a European position paper. Writing Group on Women's Health of the Fondazione Giovanni Lorenzini Medical Science Foundation

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900084-2

7 January 2021

Hormone therapy to prevent disease and prolong life in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900084-2

7 January 2021

Reduced mortality associated with long-term postmenopausal estrogen therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900084-2

7 January 2021

Cause-specific mortality in women receiving hormone replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900084-2

7 January 2021

Postmenopausal hormone therapy and mortality.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900084-2

7 January 2021

Cancer incidence and mortality in women receiving estrogen and estrogen-progestin replacement therapy--long-term follow-up of a Swedish cohort.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900084-2

7 January 2021

Noncardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II).

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900084-2

7 January 2021

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900084-2

7 January 2021

Hormone replacement therapy and the risk of death from breast cancer: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900084-2

7 January 2021

The prevention of breast cancer through reduced ovarian steroid exposure

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900084-2

7 January 2021

Hormonal regulation of apoptosis in breast cells and tissues

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900084-2

7 January 2021

Induction of apoptosis by tamoxifen and ICI 182780 in primary breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900084-2

7 January 2021

Is estradiol a genotoxic mutagenic carcinogen?

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900084-2

7 January 2021

Differential gene regulation by the two progesterone receptor isoforms in human breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900084-2

7 January 2021

Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900084-2

7 January 2021

Progestins and breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900084-2

7 January 2021

Metabolism of estrone sulfate by normal breast tissue: influence of menopausal status and oral contraceptives

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900084-2

7 January 2021

Proapoptotic effects of antiestrogens, progestins and androgen in breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900084-2

7 January 2021

Estrogen and progesterone receptor content in breast epithelial cells from healthy women during the menstrual cycle

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900084-2

7 January 2021

Effects of hormone replacement therapy on the mammary gland of surgically postmenopausal cynomolgus macaques

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900084-2

7 January 2021

Postmenopausal hormone replacement therapy and cancer of the female genital tract and breast

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900084-2

7 January 2021

Effects of estrogens and hormone replacement therapy on breast cancer risk and on efficacy of breast cancer therapies

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900084-2

7 January 2021

Reproductive factors and breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900084-2

7 January 2021

Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900084-2

7 January 2021

Intratumoral levels of estrogens in breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900084-2

7 January 2021

Increased Risk of Endometrial Carcinoma among Users of Conjugated Estrogens

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900084-2

7 January 2021

Decline in incidence of endometrial cancer following increase in prescriptions for opposed conjugated estrogens in a prepaid health plan

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900084-2

7 January 2021

Influence of non-contraceptive exogenous and endogenous sex hormones on breast cancer risk in Denmark.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900084-2

7 January 2021

The risk of breast cancer after estrogen and estrogen-progestin replacement

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900084-2

7 January 2021

The Use of Estrogens and Progestins and the Risk of Breast Cancer in Postmenopausal Women

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900084-2

7 January 2021

Long-term hormone replacement therapy and risk of breast cancer in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900084-2

7 January 2021

Hormone replacement therapy and the risk of breast cancer. Nested case-control study in a cohort of Swedish women attending mammography screening

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900084-2

7 January 2021

Risks of breast and endometrial cancer after estrogen and estrogen-progestin replacement

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900084-2

7 January 2021

Breast-cancer risk following long-term oestrogen- and oestrogen-progestin-replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900084-2

7 January 2021

Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900084-2

7 January 2021

Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900084-2

7 January 2021

Hormone replacement therapy in relation to risk of lobular and ductal breast carcinoma in middle-aged women

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900084-2

7 January 2021

Hormone replacement therapy in relation to breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900084-2

7 January 2021

Does menopausal hormone replacement therapy interact with known factors to increase risk of breast cancer?

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900084-2

7 January 2021

Pathologic and biological prognostic factors of breast cancers in short- and long-term hormone replacement therapy users

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900084-2

7 January 2021

Effects of hormone replacement therapy for menopause on prognostic factors of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900084-2

7 January 2021

Postmenopausal hormone replacement therapy: effect on diagnosis and outcome in early-stage invasive breast cancer treated with conservative surgery and radiation

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900084-2

7 January 2021

Prognostic characteristics in breast cancers after hormone replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900084-2

7 January 2021

Impact of menopausal hormone-replacement therapy on clinical and laboratory characteristics of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900084-2

7 January 2021

Breast carcinoma developing in patients on hormone replacement therapy: a histological and immunohistological study

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900084-2

7 January 2021

Low biologic aggressiveness in breast cancer in women using hormone replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900084-2

7 January 2021

Prognosis of breast cancers detected in women receiving hormone replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900084-2

7 January 2021

Hormone replacement therapy and tumour grade in breast cancer: prospective study in screening unit

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900084-2

7 January 2021

Postmenopausal estrogen replacement therapy is associated with adverse breast cancer prognostic indices

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900084-2

7 January 2021

Hormone replacement therapy and high S phase in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900084-2

7 January 2021

Clinical and biologic prognostic factors in breast cancer diagnosed during postmenopausal hormone replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900084-2

7 January 2021

Increased incidence of small and well-differentiated breast tumours in post-menopausal women following hormone-replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900084-2

7 January 2021

Estrogen replacement therapy and breast cancer: analysis of age of onset and tumor characteristics

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900084-2

7 January 2021

Circulating levels of sex hormones and their relation to risk factors for breast cancer: a cross-sectional study in 1092 pre- and postmenopausal women (United Kingdom).

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900084-2

7 January 2021

Obesity and breast cancer risk

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900084-2

7 January 2021

Serum hormones and the alcohol-breast cancer association in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900084-2

7 January 2021

Does postmenopausal estrogen administration increase the risk of breast cancer? Contributions of animal, biochemical, and clinical investigative studies to a resolution of the controversy

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900084-2

7 January 2021

Postmenopausal hormone replacement in the woman with a reproductive risk factor for breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900084-2

7 January 2021

The genetics of breast and ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900084-2

7 January 2021

The role of estrogen in mammary carcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900084-2

7 January 2021

Hormone replacement therapy after breast cancer: a systematic review and quantitative assessment of risk

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900084-2

7 January 2021

Hormone replacement therapy after a diagnosis of breast cancer in relation to recurrence and mortality

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900084-2

7 January 2021

The role of hormone replacement therapy in women with a previous diagnosis of breast cancer and a review of possible alternatives

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900084-2

7 January 2021

Hormone replacement in women with a history of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900084-2

7 January 2021

Tibolone: a steroid with a tissue-specific mode of action

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900084-2

7 January 2021

Raloxifene: risks and benefits

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900084-2

7 January 2021

Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900084-2

7 January 2021

Tibolone and its effects on bone: a review

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900084-2

7 January 2021

In vitro studies of tibolone in breast cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900084-2

7 January 2021

Continued breast cancer risk reduction in postmenopausal women treated with raloxifene: 4-year results from the MORE trial. Multiple outcomes of raloxifene evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900084-2

7 January 2021

Raloxifene and cardiovascular events in osteoporotic postmenopausal women: four-year results from the MORE (Multiple Outcomes of Raloxifene Evaluation) randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900084-2

7 January 2021

The nature and utility of the phytoestrogens: a review of the evidence

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900084-2

7 January 2021

Megestrol Acetate for the Prevention of Hot Flashes

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900084-2

7 January 2021

Physiology of hot flashes

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900084-2

7 January 2021

Phase III evaluation of fluoxetine for treatment of hot flashes

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900084-2

7 January 2021

Low-dose oestradiol in the treatment of urogenital oestrogen deficiency--a pharmacokinetic and pharmacodynamic study

1 reference

https://api.crossref.org/works/10.1016%2FS1521-690X%2802%2900084-2

7 January 2021

10.1016/S1521-690X(02)00084-2

Identifiers

DOI

1 reference

6 August 2017

1 reference